openPR Logo
Press release

Retinal Vascular Occlusion Market 2018-2023 Ongoing Trend | Estimated to Reach US$ 20.7 Billion Regeneron Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis AG, Pfizer, Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Johnson & Johnson, Teva

10-10-2018 04:17 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Retinal Vascular Occlusion Market

Retinal Vascular Occlusion Market

Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot. RVO may result in a sudden loss of vision, which can be permanent if not treated urgently. RVO is a common vascular disorder and one of the most common causes of vision loss worldwide. Taking into consideration other eye diseases RVO is the second most common cause of blindness after diabetic retinopathy. RVO affects one eye. However, approximately 6%-14% of cases it can also affect both eyes. RVO has an incidence rate of 2.2 cases per 1000 of general population older than 40 years and 5.4 cases per 1000 of general population older than 64 years.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4899

The global retinal vascular occlusion market is experiencing growing demand due to increasing older population, increasing screening, greater emphasis on restorative procedures, the urgency of the RVO treatment, and others. The market restraints are the complications such as the risk of bleeding, infections, pain, especially during surgery, the high cost of retinal vascular occlusion treatment, lack of eye care infrastructure, and lack of focus on other diseases by developing regions, and others.

The global retinal vascular occlusion market is expected to reach USD 20.7 billion by 2023, and the market is projected to grow at a CAGR of ~ 9.5 % during the forecast period 2017-2023.

Segments

The global retinal vascular occlusion market has been segmented on the basis of types, condition, diagnosis, drugs, surgery, and end user.

Based on the types, the market has been segmented as retinal artery occlusion & retinal vascular occlusion.

Based on the condition, the market has been segmented as non-ischemic and ischemic.

Based on the diagnosis, the market has been segmented as fundoscopic examination, optical coherence tomography (OCT), fluorescein angiography, and others.

Based on the drugs, the market has been segmented as an anti-vascular endothelial growth factor (VEGF), corticosteroid, anticoagulants, fibrinolytic, and others.

Based on the surgery, the market has been segmented as laser retinal photocoagulation, chorioretinal venous anastomosis, radial optic neurotomy, and others.

Based on the end user, the market has been segmented as hospitals and clinics, research and academics, and others.

Key Players

Some of the key players profiled in the report are Regeneron Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis AG, Pfizer, Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Johnson & Johnson, Teva pharmaceutical industries, Novo Nordisk, Sanofi, and others.

Regional Analysis

The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of ophthalmology procedures due to greater healthcare penetration in the U.S. and Canada drives the retinal vascular occlusion market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of ophthalmology procedures, especially, the retinal vascular occlusion surgery treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retinal vascular occlusion market in the US. The high development of the microsurgery field in developed regions such as the U.S. and Europe is a strong driver of the market.

Europe is the second largest market in the world due to growing pharmaceutical industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large pharmaceutical and microsurgery devices industry.

Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast-growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future retinal vascular occlusion market in the region. However, the low expenditure on ophthalmology and eye care coupled with the lack of insurance penetration in the developing regions is a dent in the market.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt, and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to the poor social development and tribal identities such as sub-Saharan Africa. The focus of the governments of poor countries on fulfilling basic healthcare relegates the retinal vascular occlusion market to the background, which hampers the development of the market.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4899

Detailed Table of Contents:

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4899

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Vascular Occlusion Market 2018-2023 Ongoing Trend | Estimated to Reach US$ 20.7 Billion Regeneron Pharmaceuticals, Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis AG, Pfizer, Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Johnson & Johnson, Teva here

News-ID: 1294373 • Views:

More Releases from Market Research Future

Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 | Johnson & Johnson, AstraZeneca, Eli Lilly, Alkermes
Navigating Schizophrenia Care Market Expected to Expand to $8.06 Billion by 2030 …
Schizophrenia Market Overview - The Schizophrenia Market Size was assessed at USD 5.5 billion in 2022 and is expected to expand from USD 5.76 billion in 2023 to USD 8.06 billion by 2030, with a compound annual growth rate (CAGR) of 4.9% during the forecast period (2023- 2030). The schizophrenia market is a significant segment within the pharmaceutical and mental healthcare industries, focused on addressing the complex needs of individuals living with
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $7.36 Billion by 2032
Revolutionizing Healing: Skin Graft Market Set to Grow at 7.01% CAGR, Reaching $ …
Skin Graft Market Overview - In 2022, the skin graft market was estimated at USD 4.00 billion. The skin graft market is expected to increase from USD 4.28 billion in 2023 to USD 7.36 billion by 2032, with a compound annual growth rate (CAGR) of 7.01% over the forecast period (2023-2032). The skin graft market plays a crucial role in the field of dermatology and wound care, providing solutions for patients with
Medical Suction Device Market Size to Exceed USD 1.80 billion by 2032, with a Robust CAGR of 4.8%
Medical Suction Device Market Size to Exceed USD 1.80 billion by 2032, with a Ro …
Medical Suction Device Market Overview - The Medical Suction Device Market was valued at USD 0.92 billion in 2021. The Medical Suction Device Market is expected to increase from USD 0.96 billion in 2022 to USD 1.80 billion by 2032, with a compound yearly growth rate (CAGR) of 4.8% over the forecast period (2023-2032). The medical suction device market plays a vital role in healthcare settings by providing efficient suction for various
Agriculture Phosphate Fertilizer Market Poised for Growth Despite Sustainability Concerns
Agriculture Phosphate Fertilizer Market Poised for Growth Despite Sustainability …
Phosphate fertilizers Market Outlook Phosphate fertilizers are the cornerstone of modern agriculture, providing crops with the essential nutrient phosphorus (P) needed for healthy growth and development. As the global population continues to rise, so does the demand for food, driving the phosphate fertilizer market towards significant growth. According to a report by Market Research Future (MRFR), the market is expected to reach a value of USD 104.02 billion by 2032, with

All 5 Releases


More Releases for RVO

Retinal Vein Occlusion Market Research Report- Growth in Future with Market Size …
Retinal vein occlusion, one of the most frequently occurring retinal vascular disorders in elderly patients, develops predominantly in individuals over age 65 years. The main risk factors for RVO include age and systemic vascular disorders. It is categorized into central RVO (CRVO) and branch RVO (BRVO) according to the site of blockage in the retinal vein. CRVO is divided further into nonischemic and ischemic types according to the perfusion status
RVO (Retinal Vein Occlusion) Market Structure 2018 to 2023 | by Top Internationa …
This MRFR Market Perspective Examines the Historical Trends and Current Scenario of the “Global Retinal Vein Occlusion Market” to Deliver a Highly Pertinent Growth Forecast. The primary objective of the report is to deliver Industry insights, market facts and relevant data that will allow report users to make informed decisions and device growth strategies. The Global Retinal Vein Occlusion Market is segmented on the basis of type, condition, diagnosis, treatment, and
Retinal Vein Occlusion Therapeutics Market Key Trends and Forecast Research Repo …
Retinal vein occlusion (RVO) is one of the major cause of visual loss among the geriatric population. RVO is the second common cause of blindness after diabetic retinopathy. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). The BRVO occurs when the vein in the distal retinal system gets
Global Retinal Vascular Occlusion Or RVO Market 2018 | Rising At a CAGR of 9.5% …
Market Research Future published a research report on Global Retinal Vascular Occlusion (RVO) Market and predicts that Global Retinal Vascular Occlusion (RVO) Market is expected to grow at a healthy CAGR of 9.5% during the forecasted period. The Retinal Vascular Occlusion (RVO) Market report is an expert analysis report explores the industry growth, analysis, size, share and demand supply. The Global Retinal Vascular Occlusion Market is expected to reach
Global Retinal Vascular Occlusion (RVO) Market Accretes Dramatically With a Whoo …
Market Research Future published a research report on "Global Retinal Vascular Occlusion (RVO) Market" and predicts that Global Retinal Vascular Occlusion (RVO) Market is expected to grow at a healthy CAGR of 11.48% during the forecasted period. The Retinal Vascular Occlusion (RVO) Market report is an expert analysis report explores the industry growth, analysis, size, share and demand supply. Retinal Vascular Occlusion (RVO) is the build-up of fluids in the
Market Research on Retinal Vein Occlusion Therapeutics Market 2015 and Analysis …
Retinal vein occlusion (RVO) is one of the major cause of visual loss among the geriatric population. RVO is the second common cause of blindness after diabetic retinopathy. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). The BRVO occurs when the vein in the distal retinal system gets